Rubicon Research Share Price
1671.20-61.40 (-3.54%)
+166.03% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
RUBICONNSE
Rubicon Research Share Price
1671.20-61.40 (-3.54%)
+166.03% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | 41% | 65% | 37% |
| - | 52% | - | 84% |
| - | - | - | - |
| 11% | 12% | 29% | 28% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
RUBICON
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,846.4 | ₹448196 Cr | 37.05 | 12.07 | 62.82 | ₹11479 Cr |
| 9,352 | ₹250390 Cr | 85.6 | 34.04 | 128.41 | ₹2568 Cr |
| 4,935 | ₹188967 Cr | 86.64 | 16.72 | 97.06 | ₹2163 Cr |
| 1,162.3 | ₹115860 Cr | 25.67 | 9.42 | 62.53 | ₹5040 Cr |
| 1,384.1 | ₹111888 Cr | 33.19 | 9.77 | 57.87 | ₹3879 Cr |
| 2,006.5 | ₹109035 Cr | 99.72 | 6.8 | 29.25 | ₹889 Cr |
| 2,480 | ₹100364 Cr | 49.13 | 13.75 | 71.08 | ₹1913 Cr |
| 1,211 | ₹100329 Cr | 31.14 | 5.32 | 63.99 | ₹4196 Cr |
| 1,700 | ₹98804 Cr | 26.61 | 17.95 | 96.84 | ₹3505 Cr |
| 2,135 | ₹96940 Cr | 17.53 | 30.95 | 154.36 | ₹5333 Cr |
| 1,671.2 | ₹28659 Cr | 99.43 | 5.13 | 20.48 | ₹247 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|
| ₹534 Cr | ₹514 Cr | ₹476 Cr | ₹412 Cr | ₹352 Cr | ₹358 Cr | ₹313 Cr | ₹296 Cr |
| ₹6 Cr | ₹3 Cr | ₹4 Cr | ₹70 L | ₹63 L | ₹10 L | ₹49 L | ₹3 Cr |
| ₹540 Cr | ₹517 Cr | ₹479 Cr | ₹413 Cr | ₹353 Cr | ₹358 Cr | ₹314 Cr | ₹299 Cr |
| ₹420 Cr | ₹407 Cr | ₹379 Cr | ₹330 Cr | ₹283 Cr | ₹295 Cr | ₹253 Cr | ₹242 Cr |
| ₹135 Cr | ₹121 Cr | ₹112 Cr | ₹95 Cr | ₹80 Cr | ₹73 Cr | ₹70 Cr | ₹64 Cr |
| ₹9 Cr | ₹10 Cr | ₹10 Cr | ₹11 Cr | ₹11 Cr | ₹12 Cr | ₹8 Cr | ₹7 Cr |
| ₹110 Cr | ₹99 Cr | ₹91 Cr | ₹72 Cr | ₹60 Cr | ₹51 Cr | ₹53 Cr | ₹49 Cr |
| ₹85 Cr | ₹77 Cr | ₹73 Cr | ₹54 Cr | ₹43 Cr | ₹36 Cr | ₹38 Cr | ₹34 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — |
| ₹17 Cr | ₹15 Cr | ₹15 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr |
| ₹31 Cr | ₹26 Cr | ₹24 Cr | ₹15 Cr | ₹12 Cr | ₹12 Cr | ₹8 Cr | ₹0 | ₹0 |
| ₹1241 Cr | ₹499 Cr | ₹346 Cr | ₹267 Cr | ₹288 Cr | ₹357 Cr | ₹327 Cr | ₹192 Cr | ₹174 Cr |
| ₹1241 Cr | ₹499 Cr | ₹346 Cr | ₹267 Cr | ₹288 Cr | ₹357 Cr | ₹327 Cr | ₹192 Cr | ₹174 Cr |
| ₹1289 Cr | ₹541 Cr | ₹385 Cr | ₹286 Cr | ₹305 Cr | ₹374 Cr | ₹341 Cr | ₹197 Cr | ₹178 Cr |
| ₹10,000 | ₹10,000 | ₹0 | ₹0 | ₹0 | ₹3,000 | ₹0 | ₹0 | ₹0 |
| ₹143 Cr | ₹64 Cr | ₹93 Cr | ₹97 Cr | ₹63 Cr | ₹38 Cr | ₹4 Cr | ₹28 Cr | ₹12 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹36 L | ₹35 L | ₹0 | ₹0 | ₹0 |
| -₹13 Cr | -₹2 Cr | -₹93 L | ₹1 Cr | ₹4 Cr | ₹8 Cr | -₹3 Cr | ₹30 L | ₹2 Cr |
| ₹47 Cr | ₹50 Cr | ₹55 Cr | ₹0 | ₹2 Cr | ₹5 Cr | ₹7 Cr | ₹0 | ₹0 |
| ₹12 Cr | ₹10 Cr | ₹4 Cr | ₹3 Cr | ₹1 Cr | ₹1 Cr | ₹81 L | ₹2 Cr | ₹43 L |
| ₹189 Cr | ₹123 Cr | ₹151 Cr | ₹102 Cr | ₹71 Cr | ₹53 Cr | ₹9 Cr | ₹31 Cr | ₹14 Cr |
| — | — | — | — | — | — | — | — | — |
| ₹377 Cr | ₹239 Cr | ₹177 Cr | ₹97 Cr | ₹57 Cr | ₹33 Cr | ₹19 Cr | ₹20 Cr | ₹10 Cr |
| ₹154 Cr | ₹93 Cr | ₹75 Cr | ₹46 Cr | ₹33 Cr | ₹33 Cr | ₹28 Cr | ₹25 Cr | ₹11 Cr |
| ₹68 Cr | ₹290 Cr | ₹264 Cr | ₹196 Cr | ₹91 Cr | ₹43 Cr | ₹19 Cr | ₹14 Cr | ₹14 Cr |
| ₹237 Cr | ₹164 Cr | ₹56 Cr | ₹23 Cr | ₹2 Cr | ₹1 Cr | ₹12 Cr | ₹10 Cr | ₹50 L |
| ₹836 Cr | ₹786 Cr | ₹572 Cr | ₹361 Cr | ₹184 Cr | ₹111 Cr | ₹78 Cr | ₹69 Cr | ₹35 Cr |
| ₹2314 Cr | ₹1450 Cr | ₹1109 Cr | ₹750 Cr | ₹560 Cr | ₹538 Cr | ₹427 Cr | ₹296 Cr | ₹227 Cr |
| ₹19 Cr | ₹12 Cr | ₹10 Cr | ₹9 Cr | ₹2 Cr | ₹30 Cr | ₹46 Cr | ₹48 L | ₹0 |
| ₹259 Cr | ₹393 Cr | ₹396 Cr | ₹318 Cr | ₹170 Cr | ₹93 Cr | ₹30 Cr | ₹50 Cr | ₹30 Cr |
| — | — | — | — | — | — | — | — | — |
| ₹788 Cr | ₹540 Cr | ₹492 Cr | ₹359 Cr | ₹317 Cr | ₹278 Cr | ₹218 Cr | ₹111 Cr | ₹82 Cr |
| ₹256 Cr | ₹213 Cr | ₹185 Cr | ₹160 Cr | ₹124 Cr | ₹90 Cr | ₹61 Cr | ₹43 Cr | ₹38 Cr |
| ₹532 Cr | ₹327 Cr | ₹307 Cr | ₹199 Cr | ₹193 Cr | ₹188 Cr | ₹157 Cr | ₹69 Cr | ₹44 Cr |
| ₹40 Cr | ₹7 Cr | ₹10 Cr | ₹25 Cr | ₹3 Cr | ₹6 Cr | ₹98 L | ₹44 Cr | ₹9 Cr |
| ₹27 Cr | ₹5 L | ₹5 L | ₹5 L | ₹5 L | ₹5 L | ₹5 L | ₹5 L | ₹5 L |
| ₹27 Cr | ₹5 L | ₹5 L | ₹5 L | ₹5 L | ₹5 L | ₹5 L | ₹5 L | ₹5 L |
| ₹25 Cr | ₹41 Cr | ₹16 Cr | ₹13 Cr | ₹28 Cr | ₹6 Cr | ₹3 Cr | ₹5 Cr | ₹4 Cr |
| ₹8 Cr | ₹12 Cr | ₹13 Cr | ₹11 Cr | ₹7 Cr | ₹2 Cr | ₹49 L | ₹50 L | ₹10 L |
| ₹632 Cr | ₹386 Cr | ₹345 Cr | ₹248 Cr | ₹231 Cr | ₹202 Cr | ₹162 Cr | ₹131 Cr | ₹73 Cr |
| — | — | — | — | — | — | — | — | — |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹14 Cr | ₹19 Cr | ₹12 Cr | ₹76 Cr |
| ₹729 Cr | ₹522 Cr | ₹300 Cr | ₹167 Cr | ₹90 Cr | ₹62 Cr | ₹38 Cr | ₹19 Cr | ₹14 Cr |
| ₹509 Cr | ₹324 Cr | ₹301 Cr | ₹225 Cr | ₹140 Cr | ₹136 Cr | ₹140 Cr | ₹84 Cr | ₹37 Cr |
| ₹346 Cr | ₹116 Cr | ₹58 Cr | ₹59 Cr | ₹53 Cr | ₹84 Cr | ₹36 Cr | ₹11 Cr | ₹3 Cr |
| ₹52 Cr | ₹64 Cr | ₹49 Cr | ₹19 Cr | ₹29 Cr | ₹27 Cr | ₹11 Cr | ₹10 Cr | ₹9 Cr |
| ₹46 Cr | ₹38 Cr | ₹54 Cr | ₹31 Cr | ₹18 Cr | ₹13 Cr | ₹21 Cr | ₹29 Cr | ₹15 Cr |
| ₹1682 Cr | ₹1063 Cr | ₹763 Cr | ₹502 Cr | ₹328 Cr | ₹336 Cr | ₹265 Cr | ₹165 Cr | ₹154 Cr |
| ₹846 Cr | ₹277 Cr | ₹191 Cr | ₹140 Cr | ₹145 Cr | ₹225 Cr | ₹187 Cr | ₹97 Cr | ₹120 Cr |
| ₹2314 Cr | ₹1450 Cr | ₹1109 Cr | ₹750 Cr | ₹560 Cr | ₹538 Cr | ₹427 Cr | ₹296 Cr | ₹227 Cr |
| ₹76 | ₹33 | ₹24 | ₹536 | ₹578 | ₹714 | ₹656 | ₹419 | ₹380 |
| ₹76 | ₹33 | ₹24 | ₹18 | ₹19 | ₹24 | ₹22 | ₹14 | ₹13 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|
| ₹321 Cr | ₹195 Cr | ₹103 Cr | -₹11 Cr | -₹66 Cr | ₹63 Cr | ₹74 Cr | ₹27 Cr | ₹49 L |
| ₹108 Cr | ₹93 Cr | ₹71 Cr | ₹46 Cr | ₹28 Cr | ₹34 Cr | ₹28 Cr | ₹16 Cr | ₹10 Cr |
| -₹115 Cr | -₹90 Cr | -₹135 Cr | -₹108 Cr | -₹16 Cr | -₹9 Cr | -₹70 Cr | -₹57 Cr | -₹26 Cr |
| ₹314 Cr | ₹198 Cr | ₹39 Cr | -₹73 Cr | -₹54 Cr | ₹88 Cr | ₹32 Cr | -₹14 Cr | -₹16 Cr |
| ₹205 Cr | ₹159 Cr | ₹21 Cr | -₹75 Cr | -₹63 Cr | ₹57 Cr | ₹5 Cr | -₹14 Cr | -₹16 Cr |
| -₹410 Cr | -₹65 Cr | -₹69 Cr | -₹34 Cr | -₹55 Cr | -₹36 Cr | -₹84 Cr | ₹4 Cr | ₹20 Cr |
| ₹283 Cr | -₹40 Cr | ₹44 Cr | ₹123 Cr | ₹63 Cr | ₹52 Cr | ₹80 Cr | ₹16 Cr | -₹3 Cr |
| ₹78 Cr | ₹55 Cr | -₹4 Cr | ₹14 Cr | -₹55 Cr | ₹73 Cr | ₹1 Cr | ₹7 Cr | ₹1 Cr |
| ₹105 Cr | ₹51 Cr | ₹54 Cr | ₹39 Cr | ₹84 Cr | ₹9 Cr | ₹10 Cr | ₹3 Cr | ₹2 Cr |
| ₹2 Cr | -₹19 L | ₹13 L | ₹2 Cr | ₹9 Cr | ₹3 Cr | ₹0 | ₹0 | ₹0 |
| ₹186 Cr | ₹105 Cr | ₹51 Cr | ₹54 Cr | ₹39 Cr | ₹84 Cr | ₹11 Cr | ₹10 Cr | ₹3 Cr |
Fundamental Ratios
Consolidated
Standalone
No results found
Rubicon Research Share Price
1671.20-61.40 (-3.54%)
+166.03% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 5
Bearish signals: 4 out of 9 oscillators
RSI
42.70Sell
STOCH %K
4.21Buy
MACD Level(12,26)
18.42Buy
Ultimate Oscillator
38.68Sell
Aroon Oscillator
60.00Buy
BOP
-0.71Sell
CCI
-220.35Buy
Williams %R
-95.79Buy
Momentum
-151.00Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 4
Bearish signals: 5 out of 9 moving averages
EMA 9
1754.49Sell
SMA 9
1772.38Sell
EMA 21
1755.30Sell
SMA 21
1786.86Sell
EMA 50
1654.00Buy
SMA 50
1663.73Buy
EMA 200
1138.31Buy
SMA 200
1084.61Buy
WMA 20
1777.51Sell
Pivot
Pivot
Classic
Resistance 5
1921.67
Resistance 4
1875.87
Resistance 3
1830.07
Resistance 2
1784.27
Resistance 1
1758.43
Pivot
1738.47
Support 1
1712.63
Support 2
1692.67
Support 3
1646.87
Support 4
1601.07
Support 5
1555.27
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Rubicon Research Share Price
1671.20-61.40 (-3.54%)
+166.03% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 | Dec 2025 | Oct 2025 |
|---|---|---|---|
| 59.76% | 59.86% | 59.99% | 59.99% |
| 7.52% | 7.54% | 7.99% | 9.38% |
| 2.20% | 2.88% | 2.83% | 4.12% |
| 7.23% | 7.14% | 6.61% | 5.63% |
| 23.29% | 22.58% | 22.58% | 20.88% |
Bulk & block deals
Name
Hdfc Mutual Fund
Icici Prudential Mutual Fund
Kotak Mahindra Mutual Fund
Sbi Mutual Fund
Nomura India Investment Fund Mother Fund
Axis Mutual Fund
Timf Holdings
Aranda Investments Pte. Ltd.
General Atlantic Singapore Rr Pte Ltd
General Atlantic Singapore Rr Pte Ltd
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 26 Aug 2026 | Purchase | 809.75 Cr | ₹1,660 | 48.78 L | Bulk | 2.946869 | BSE |
| 26 Aug 2026 | Purchase | 300 Cr | ₹1,660 | 18.07 L | Bulk | 1.091769 | BSE |
| 26 Aug 2026 | Purchase | 275 Cr | ₹1,660 | 16.57 L | Bulk | 1.000788 | BSE |
| 26 Aug 2026 | Purchase | 200 Cr | ₹1,660 | 12.05 L | Bulk | 0.727845 | BSE |
| 26 Aug 2026 | Purchase | 199.86 Cr | ₹1,660 | 12.04 L | Bulk | 0.727352 | BSE |
| 26 Aug 2026 | Purchase | 150 Cr | ₹1,660 | 9.04 L | Bulk | 0.545883 | BSE |
| 26 Aug 2026 | Purchase | 150 Cr | ₹1,660 | 9.04 L | Bulk | 0.545883 | BSE |
| 26 Aug 2026 | Purchase | 140 Cr | ₹1,660 | 8.43 L | Bulk | 0.509492 | NSE |
| 26 Aug 2026 | Sell | 2,159.61 Cr | ₹1,660 | 1.30 Cr | Bulk | 7.859332 | BSE |
| 26 Aug 2026 | Sell | 140 Cr | ₹1,660 | 8.43 L | Bulk | 0.509492 | NSE |
Insider trading & SAST
Client name
Girish Subramaniam Iyer
Girish Subramaniam Iyer
Girish Subramaniam Iyer
Girish Subramaniam Iyer
Vinayak Sawant
General Atlantic Singapore Rr Pte Ltd
General Atlantic Singapore Rr Pte Ltd
Sanjay Renapurkar
Sanjay Renapurkar
Sarabjit Singh
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15 Sep 2026 | Employee | Disposal | 0.001812 | 0.03 | 54.89 L | ₹1,829.80 | 3 K | 11 Sep 2026 | Market Sale | 48,220 | Insider Trading | — | Equity |
| 15 Sep 2026 | Employee | Disposal | 0.000906 | 0.03 | 27.32 L | ₹1,821 | 1.50 K | 09 Sep 2026 | Market Sale | 52,516 | Insider Trading | — | Equity |
| 15 Sep 2026 | Employee | Disposal | 0.000783 | 0.03 | 23.18 L | ₹1,788.48 | 1.30 K | 10 Sep 2026 | Market Sale | 51,220 | Insider Trading | — | Equity |
| 15 Sep 2026 | Employee | Disposal | 0.000604 | 0.03 | 18.10 L | ₹1,809.90 | 1 K | 08 Sep 2026 | Market Sale | 54,016 | Insider Trading | — | Equity |
| 04 Sep 2026 | Employee | Disposal | 0.000665 | 0 | 20.28 L | ₹1,843.54 | 1.10 K | 28 Aug 2026 | Market Sale | 7,307 | Insider Trading | — | Equity |
| 28 Aug 2026 | Promoter | Disposal | 8.368824 | 27.34 | 2,299.61 Cr | ₹1,660 | 1.39 Cr | 26 Aug 2026 | Market Sale | 4,52,58,360 | Insider Trading | — | Equity |
| 28 Aug 2026 | Promoter | Disposal | 0.088761 | 35.7 | 25.42 Cr | ₹1,729.82 | 1.47 L | 25 Aug 2026 | Market Sale | 5,91,11,433 | Insider Trading | — | Equity |
| 25 Aug 2026 | Employee | Disposal | 0.002416 | 0 | 70.10 L | ₹1,752.50 | 4 K | 19 Aug 2026 | Market Sale | 2,000 | Insider Trading | — | Equity |
| 25 Aug 2026 | Employee | Disposal | 0.001208 | 0 | 35.81 L | ₹1,790.54 | 2 K | 20 Aug 2026 | Market Sale | 0 | Insider Trading | — | Equity |
| 21 Aug 2026 | Employee | Disposal | 0.021144 | 0.15 | 1.75 K | ₹0.05 | 35 K | 18 Aug 2026 | Market Sale | 2,46,816 | Insider Trading | — | Equity |
Rubicon Research Share Price
1671.20-61.40 (-3.54%)
+166.03% past 1 Year
Rubicon Research is an integrated pharmaceutical company with business encompassing the entire value chain in the research, development and production of pharmaceutical products. Further, the company has robust sales and
Corporate Actions
Date
Type
Details
Company details
Rubicon Research Share Price
1671.20-61.40 (-3.54%)
+166.03% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Rubicon Research Share Price
1671.20-61.40 (-3.54%)
+166.03% past 1 Year
News
Rubicon Research reports Profit after tax of 70.02 Crores, in the March 2026 quarter
Equity
RUBICON
Rubicon Research reports higher Q4 EBITDA and improved margin
Equity
RUBICON
Rubicon Research Q4 results show strong profit and revenue growth YoY
Equity
RUBICON
USFDA completes inspection at Rubicon Research’s R&D facility in Canada
Equity
RUBICON
Rubicon Research informs about disclosure
Equity
RUBICON
Rubicon Research gains on inking pact to acquire 85% stake in Arinna Lifesciences
Equity
RUBICON
Motilal Oswal Maintains Buy on Rubicon Research, Raises Target to Rs 955.
Equity
RUBICON
Rubicon Research Acquires 85% Stake in Arinna Lifesciences for Rs 200 Crores.
Equity
RUBICON
Rubicon Research to acquire 85% stake in Arinna Lifesciences
Equity
RUBICON
Rubicon Research - Quaterly Results
Equity
RUBICON
Rubicon Research Reports Strong Q3 EBITDA Growth to Rs 110 Crores, Margin at 22.75%.
Equity
RUBICON
Rubicon Research Q3 Consolidated Net Profit Rises 91% YoY to Rs 72.80 Crores, Revenue Up 52% to Rs 476 Crores.
Equity
RUBICON
Rubicon Research informs about outcome of board meeting
Equity
RUBICON
Rubicon Research reports Profit after tax of 37.18 Crores, in the December 2025 quarter
Equity
RUBICON
Rubicon Research rises on incorporating wholly owned subsidiary in Saudi Arabia
Equity
RUBICON
Rubicon Research guides for strong Q2FY26 growth, targets expansion and plant commissioning.
Equity
RUBICON
Rubicon Research posts strong YoY growth in Q2 FY26 EBITDA and margin improvement.
Equity
RUBICON
Rubicon Research reports Q2 FY2025 consolidated net profit and revenue growth on YoY basis.
Equity
RUBICON
Rubicon Research reports Profit after tax of 45.81 Crores, in the September 2025 quarter
Equity
RUBICON
Rubicon Research to acquire common stock in Neuronasal
Equity
RUBICON